FONTEYNE PAUL R.
SEC insider (Form 3/4/5 filer). CIK 0001727550. Director at Apnimed, Inc. (APMD) and 2 other issuers. 17 reported Form 4/5 transactions since Sep 2024; latest on Aug 3, 2026. Located in CAMBRIDGE, MA.
Companies FONTEYNE PAUL R. has filed insider reports for
- Apnimed, Inc. (APMD): Director
- Amylyx Pharmaceuticals, Inc. (AMLX): Director
- Apellis Pharmaceuticals, Inc. (APLS): Director
FONTEYNE PAUL R.
CIK: 0001727550
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Aug 3, 2026APMD
Apnimed, Inc.
AwardDirectStock Option (Right to Buy)
44.5K shares- - Aug 3, 2026APMD
Apnimed, Inc.
AwardDirectStock Option (Right to Buy)
44.5K shares- - Aug 3, 2026APMD
Apnimed, Inc.
DispositionDirectStock Option (Right to Buy)
44.5K shares- - Aug 3, 2026APMD
Apnimed, Inc.
DispositionDirectStock Option (Right to Buy)
51.9K shares- - Aug 3, 2026APMD
Apnimed, Inc.
AwardDirectStock Option (Right to Buy)
51.9K shares- - Aug 3, 2026APMD
Apnimed, Inc.
DispositionDirectStock Option (Right to Buy)
44.5K shares- - Jul 30, 2026APMD
Apnimed, Inc.
AwardDirectStock Option (Right to Buy)
44.5K shares- - Jun 4, 2026AMLX
Amylyx Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
24.4K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect3.1K shares- - May 14, 2026APLS
Apellis Pharmaceuticals, Inc.
DispositionDirect5.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 3, 2026 |  APMD Apnimed, Inc. | Award Stock Option (Right to Buy) | 44,477 | - | - | Direct |
| Aug 3, 2026 | APMD Apnimed, Inc. | Award Stock Option (Right to Buy) | 44,477 | - | - | Direct |
| Aug 3, 2026 | APMD Apnimed, Inc. | Disposition Stock Option (Right to Buy) | 44,477 | - | - | Direct |
| Aug 3, 2026 | APMD Apnimed, Inc. | Disposition Stock Option (Right to Buy) | 51,890 | - | - | Direct |
| Aug 3, 2026 | APMD Apnimed, Inc. | Award Stock Option (Right to Buy) | 51,890 | - | - | Direct |
| Aug 3, 2026 | APMD Apnimed, Inc. | Disposition Stock Option (Right to Buy) | 44,477 | - | - | Direct |
| Jul 30, 2026 | APMD Apnimed, Inc. | Award Stock Option (Right to Buy) | 44,477 | - | - | Direct |
| Jun 4, 2026 |  AMLX Amylyx Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 24,372 | - | - | Direct |
| May 14, 2026 |  APLS Apellis Pharmaceuticals, Inc. | Disposition | 3,062 | - | $0 | Direct |
| May 14, 2026 | APLS Apellis Pharmaceuticals, Inc. | Disposition | 5,744 | - | $0 | Direct |
1-10 of 17 transactions